FDA approves label update of Cosentyx to include scalp psoriasis
9 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The FDA has approved a label update for Cosentyx, the first interleukin-17A inhibitor approved to treat moderate-to-severe plaque psoriasis...
Follow: